3 recruiting, 2 completed, 1 active not recruiting, 1 terminated. 3 Phase 1, 3 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Early Phase 1 | 1 | Active not recruiting 1 |
Follow Apollo Therapeutics Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis Camoteskimab, Placebo - Atopic Dermatitis, Atopic | Phase 2 | Recruiting | Apollo Therapeutics Ltd | 280 | 2026-05-28 | 2026-08-28 |
| A Study of APL-10456-Vaccine APL-10456-Vaccine, Placebo - Rhinovirus | Early Phase 1 | Active not recruiting | Apollo Therapeutics Ltd | 144 | 2026-02-16 | 2026-05-27 |
| A Trial of "APL-9796'' in Adults With Pulmonary Hypertension APL-9796 - Pulmonary Arterial Hypertension | Phase 2 | Recruiting | Apollo Therapeutics Ltd | 48 | 2025-04-09 | 2026-05-11 |
| A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors APL-5125 - Colorectal Cancer, Cholangiocarcinoma | Phase 1 | Completed | Apollo Therapeutics Ltd | 27 | 2024-06-18 | 2026-10-05 |
| A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS APL-4098, Azacitidine and APL-4098, Azacitidine and Venetoclax and APL-4098 - Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Acute Myeloid Leukemia | Phase 1 | Recruiting | Apollo Therapeutics Ltd | 100 | 2024-06-04 | 2026-10-28 |
| A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis Camoteskimab, Placebo - Atopic Dermatitis, Atopic | Phase 2 | Completed | Apollo Therapeutics Ltd | 62 | 2024-05-01 | 2025-09-18 |
| A Study to Evaluate Camoteskimab in Participants With Still's Disease Camoteskimab (CERC-007, AVTX-007, AEVI-007) - Adult Onset Still's Disease | Phase 1 | Terminated | Apollo Therapeutics Ltd | 5 | 2021-03-25 | 2023-08-23 |
Dermatitis (2) · Dermatitis, Atopic (2) · Eczema (2) · Skin Diseases (2) · Adenocarcinoma, Mucinous (1) · Anemia, Refractory, with Excess of Blasts (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · GATA2 Deficiency (1) · Hypertension, Pulmonary (1) · Leukemia, Myeloid, Acute (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Pulmonary Arterial Hypertension (1) · Still's Disease, Adult-Onset (1)
Azacitidine (1) · venetoclax (1)
United States (4) · Australia (2) · Canada (2) · Poland (2) · United Kingdom (2) · Belgium (1) · Bulgaria (1) · Czechia (1) · Germany (1) · Hungary (1) · Spain (1) · Ukraine (1)